These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24915026)

  • 1. Botulinum toxin A, brain and pain.
    Matak I; Lacković Z
    Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons.
    Matak I; Rossetto O; Lacković Z
    Pain; 2014 Aug; 155(8):1516-1526. PubMed ID: 24793910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
    Mazzocchio R; Caleo M
    Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A.
    Aoki KR; Francis J
    Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S28-33. PubMed ID: 21999893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
    Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
    Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
    Dolly JO; Wang J; Zurawski TH; Meng J
    FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What have we learned about antinociceptive effect of botulinum toxin type A from mirror-image pain models?
    Drinovac Vlah V; Bach-Rojecky L
    Toxicon; 2020 Oct; 185():164-173. PubMed ID: 32698026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis.
    Nemanić D; Mustapić M; Matak I; Bach-Rojecky L
    Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A.
    Matak I; Bach-Rojecky L; Filipović B; Lacković Z
    Neuroscience; 2011 Jul; 186():201-7. PubMed ID: 21539899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?
    Caleo M; Antonucci F; Restani L; Mazzocchio R
    J Neurochem; 2009 Apr; 109(1):15-24. PubMed ID: 19154335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin and Pain.
    Lacković Z
    Handb Exp Pharmacol; 2021; 263():251-264. PubMed ID: 32016565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
    Oh HM; Chung ME
    Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central origin of the antinociceptive action of botulinum toxin type A.
    Bach-Rojecky L; Lacković Z
    Pharmacol Biochem Behav; 2009 Dec; 94(2):234-8. PubMed ID: 19732788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
    Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
    J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A closer look to botulinum neurotoxin type A-induced analgesia.
    Guo BL; Zheng CX; Sui BD; Li YQ; Wang YY; Yang YL
    Toxicon; 2013 Sep; 71():134-9. PubMed ID: 23747735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Botulinum Toxin for the Treatment of Chronic Joint Pain: Clinical and Experimental Evidence.
    Blanshan N; Krug H
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A
    BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.
    Kim DW; Lee SK; Ahnn J
    Toxins (Basel); 2015 Jun; 7(7):2435-53. PubMed ID: 26134255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.